Sign in

CIK 0001737953 · Non-accelerated filer<br>Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
operating
EIN
822082553
Phone
(781) 222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
  1. UPLOAD Other SEC-generated Letter
  2. DEF 14A Proxy Proxy Statement
  3. 8-K Event Material agreement · New debt or obligation
  4. S-3 Offering Registration Statement
  5. UPLOAD Other SEC-generated Letter
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. PRER14A Other PRER14A
  8. UPLOAD Other SEC-generated Letter
  9. PRE 14A Proxy Proxy Statement (Preliminary)
  10. 10-K/A Report 10-K/A
  11. 10-K Report Annual Report
  12. 8-K Event Results of operations
  13. 8-K Event Material agreement
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 29 of 34 · 662 filings